Macquarie Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-13,831
| Closed | -$193K | – | 1360 |
|
|
2025
Q3 | $193K | Buy |
13,831
+7,510
| +119% | +$108K | ﹤0.01% | 1488 |
|
|
2025
Q2 | $95K | Hold |
6,321
| – | – | ﹤0.01% | 1575 |
|
|
2025
Q1 | $83K | Buy |
6,321
+2,430
| +62% | +$33.5K | ﹤0.01% | 1558 |
|
|
2024
Q4 | $61K | Buy |
3,891
+1,941
| +100% | +$29.2K | ﹤0.01% | 1559 |
|
|
2024
Q3 | $31K | Buy |
+1,950
| New | +$31.4K | ﹤0.01% | 1606 |
|
|
2022
Q3 | – | Sell |
-2,005
| Closed | -$22K | – | 2534 |
|
|
2022
Q2 | $22K | Sell |
2,005
-2,520
| -56% | -$27.4K | ﹤0.01% | 2280 |
|
|
2022
Q1 | $50K | Buy |
+4,525
| New | +$51.3K | ﹤0.01% | 2142 |
|
|
2020
Q4 | – | Sell |
-520,660
| Closed | -$7.24M | – | 2375 |
|
|
2020
Q3 | $7.24M | Hold |
520,660
| – | – | 0.01% | 730 |
|
|
2020
Q2 | $5.52M | Sell |
520,660
-526,835
| -50% | -$5.36M | 0.01% | 777 |
|
|
2020
Q1 | $8.45M | Sell |
1,047,495
-575,420
| -35% | -$4.8M | 0.02% | 600 |
|
|
2019
Q4 | $13.2M | Hold |
1,622,915
| – | – | 0.02% | 602 |
|
|
2019
Q3 | $12.3M | Sell |
1,622,915
-253,300
| -14% | -$1.88M | 0.02% | 558 |
|
|
2019
Q2 | $14.1M | Buy |
1,876,215
+95,000
| +5% | +$747K | 0.02% | 538 |
|
|
2019
Q1 | $14.4M | Buy |
1,781,215
+12,500
| +0.7% | +$95K | 0.02% | 546 |
|
|
2018
Q4 | $13.3M | Buy |
1,768,715
+718,715
| +68% | +$5.05M | 0.03% | 536 |
|
|
2018
Q3 | $7.27M | Buy |
+1,050,000
| New | +$7.02M | 0.01% | 703 |
|
|
2016
Q1 | – | Sell |
-175
| Closed | -$2K | – | 1579 |
|
|
2015
Q4 | $2K | Sell |
175
-38,410
| -100% | -$421K | ﹤0.01% | 1505 |
|
|
2015
Q3 | $493K | Buy |
38,585
+3,700
| +11% | +$46K | ﹤0.01% | 1253 |
|
|
2015
Q2 | $386K | Buy |
34,885
+615
| +2% | +$6.79K | ﹤0.01% | 1342 |
|
|
2015
Q1 | $391K | Sell |
34,270
-42,295
| -55% | -$449K | ﹤0.01% | 1318 |
|
|
2014
Q4 | $773K | Sell |
76,565
-42,920
| -36% | -$452K | ﹤0.01% | 1204 |
|
|
2014
Q3 | $1.26M | Buy |
119,485
+60,940
| +104% | +$573K | ﹤0.01% | 1126 |
|
|
2014
Q2 | $505K | Sell |
58,545
-13,060
| -18% | -$110K | ﹤0.01% | 1310 |
|
|
2014
Q1 | $629K | Sell |
71,605
-18,710
| -21% | -$163K | ﹤0.01% | 1237 |
|
|
2013
Q4 | $741K | Buy |
90,315
+34,520
| +62% | +$273K | ﹤0.01% | 1209 |
|
|
2013
Q3 | $422K | Sell |
55,795
-6,635
| -11% | -$48.3K | ﹤0.01% | 1323 |
|
|
2013
Q2 | $472K | Buy |
+62,430
| New | +$456K | ﹤0.01% | 1280 |
|
Other funds holding RDY
AIM
Macquarie Group's RDY Position: Q4 2025 in Review
Macquarie Group sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 13,831 shares — an estimated $193K sold.
Macquarie Group first reported a position in RDY in Q2 2013 and held it in 27 quarters. The position peaked at $14.4M in Q1 2019. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.
- Macquarie Group reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 13,831 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $193K.
- Macquarie Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 27 quarters.
- Macquarie Group's Dr. Reddy's Laboratories position peaked at $14.4M in Q1 2019.
- 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.